Your browser doesn't support javascript.
loading
Changes in PCSK9 and LDL cholesterol concentrations by everolimus treatment and their effects on polymorphisms in PCSK9 and mTORC1.
Sato, Shiori; Akamine, Yumiko; Kagaya, Hideaki; Saito, Mitsuru; Inoue, Takamitsu; Numakura, Kazuyuki; Habuchi, Tomonori; Satoh, Shigeru; Miura, Masatomo.
Afiliação
  • Sato S; Department of Pharmacy, Akita University Hospital, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Akamine Y; Department of Pharmacy, Akita University Hospital, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Kagaya H; Department of Pharmacy, Akita University Hospital, 1-1-1 Hondo, Akita, 010-8543, Japan.
  • Saito M; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Inoue T; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Numakura K; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Habuchi T; Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Satoh S; Center for Kidney Disease and Transplantation, Akita University Hospital, 1-1-1 Hondo, Akita, Japan.
  • Miura M; Department of Pharmacy, Akita University Hospital, 1-1-1 Hondo, Akita, 010-8543, Japan. m-miura@hos.akita-u.ac.jp.
Pharmacol Rep ; 72(3): 622-630, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32215854

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Everolimo / Pró-Proteína Convertase 9 / LDL-Colesterol Limite: Female / Humans / Male Idioma: En Revista: Pharmacol Rep Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Everolimo / Pró-Proteína Convertase 9 / LDL-Colesterol Limite: Female / Humans / Male Idioma: En Revista: Pharmacol Rep Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão